Vor Biopharma, Inc. (VOR)
24.27
+1.56
(+6.87%)
USD |
NASDAQ |
Aug 25, 13:41
Vor Biopharma 1 Year Total Returns (Daily) : -47.67% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -47.67% |
| August 21, 2026 | -46.18% |
| August 20, 2026 | -47.58% |
| August 19, 2026 | -42.49% |
| August 18, 2026 | -42.94% |
| August 17, 2026 | -46.24% |
| August 14, 2026 | -41.84% |
| August 13, 2026 | -42.35% |
| August 12, 2026 | -32.71% |
| August 11, 2026 | -40.73% |
| August 10, 2026 | -43.55% |
| August 07, 2026 | -42.83% |
| August 06, 2026 | -43.30% |
| August 05, 2026 | -48.92% |
| August 04, 2026 | -47.27% |
| August 03, 2026 | -49.02% |
| July 31, 2026 | -48.91% |
| July 30, 2026 | -50.68% |
| July 29, 2026 | -58.40% |
| July 28, 2026 | -58.68% |
| July 27, 2026 | -55.82% |
| July 24, 2026 | -55.62% |
| July 23, 2026 | -54.59% |
| July 22, 2026 | -52.41% |
| July 21, 2026 | -51.10% |
| Date | Value |
|---|---|
| July 20, 2026 | -60.52% |
| July 17, 2026 | -62.00% |
| July 16, 2026 | -59.10% |
| July 15, 2026 | -59.73% |
| July 14, 2026 | -61.30% |
| July 13, 2026 | -63.94% |
| July 10, 2026 | -58.57% |
| July 09, 2026 | -61.12% |
| July 08, 2026 | -57.69% |
| July 07, 2026 | -62.36% |
| July 06, 2026 | -47.38% |
| July 02, 2026 | -29.00% |
| July 01, 2026 | -35.70% |
| June 30, 2026 | -43.18% |
| June 29, 2026 | -12.26% |
| June 26, 2026 | -9.55% |
| June 25, 2026 | 34.65% |
| June 24, 2026 | 127.6% |
| June 23, 2026 | 156.0% |
| June 22, 2026 | 210.9% |
| June 18, 2026 | 238.6% |
| June 17, 2026 | 264.2% |
| June 16, 2026 | 218.2% |
| June 15, 2026 | 286.3% |
| June 12, 2026 | 246.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Dyne Therapeutics, Inc. | 106.6% |
| Agenus, Inc. | 69.69% |
| Amgen, Inc. | 55.28% |
| Anika Therapeutics, Inc. | 121.1% |
| BioCryst Pharmaceuticals, Inc. | 13.08% |